Skip to main content
Premium Trial:

Request an Annual Quote

Health Discovery Files Patent Infringement Suits Against Ciphergen, Equbits

NEW YORK, June 27 (GenomeWeb News) - Biomarker-discovery firm Health Discovery said today that it has filed patent infringement lawsuits against Ciphergen Biosystems and Equbits in the United States District Court in Marshall, Texas.

 

The lawsuit alleges that Ciphergen and Equbits have infringed three of Health Discovery's US patents covering various aspects of the company's support vector machine technology.

 

In the complaints, Health Discovery seeks "injunctive relief from further infringement, compensatory damages, enhanced damages, reasonable attorney's fees, prejudgment interest, and other associated costs," the company said.

 

Health Discovery uses its support vector machine pattern-recognition technology to discover biomarkers and biological pathways. The company said the technology also has potential applications in markets such as radiology, Internet search and spam, homeland security, financial futures, and other areas where analysis of large volumes of complex data is required.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.